김기형

  #부인종양학#일반산부인과학

학력

부산의대 졸업
부산대학교 대학원 석사, 박사
의료경영최고관리자과정 수료

경력

부산대학교병원 산부인과 진료과장 (2011-2016)
부산대학교병원 홍보실장 (2017-2018)
재단법인 의학연구재단 이사 (2017-2018)
현) 부산지방법원(서부지원) 조정위원(2017-)
현) 부산대학교 의학전문대학원 산부인과학교실 주임교수

논문

Updated on May 2, 2018

주요 저서 : 부인과학 (제5판): 종양유전학, 산부인과 내시경학 (제3판)
주요 논문 : 난소암, 자궁경부암, 자궁내막암, 자궁내막증

Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review. Cancer Res Treat. 2018

Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer. J Cancer. 2018

Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma. J Cancer. 2018

Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses. J Cancer. 2018

The Neutrophil-Lymphocyte Ratio Predicts Recurrence of Cervical Intraepithelial Neoplasia, Journal of Cancer, 2017;8(12):2205-2211

Long interspersed element-1 open reading frame 1 protein expression profiles in ovarian cancers. Genes Genom, 2017;39:1157?1162

Laparoscopically assisted suprapubic surgery for adnexal tumors under epidural anesthesia. Minim Invasive Ther Allied Technol. 2017;26(1):39-43

NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells. Oncotarget. 2016;7(44):72148-72166.

The lymphocyte-monocyte ratio predicts patient survival and aggressiveness of ovarian cancer. Journal of Cancer, 2016;7(3):289-96

Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer. Journal of Cancer, 2016; 7(13): 1772-1779

The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer. Journal of Cancer, 2016;7(5):538-545.

Changes in Bone Density after Cancer Treatment in Patients with Cervical and Endometrial Cancer. Journal of Cancer, 2015;6(1):82-89.

DDX4 Colocalizes with Cancer Stem Cell Marker CD133 in Ovarian Cancers. Biochemical and Biophysical Research Communications, 2014;447(2):315-22

Silibinin Inhibits Tumor Growth through Downregulation of Extracellular Signal-Regulated Kinase and Akt in Vitro and in Vivo in Human Ovarian Cancer Cells. Journal of Agricultural and Food Chemistry. 2013;61(17):4089-4096

Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1/ERK/Akt signaling in human breast cancer cells. J Pharmacol Exp Ther. 2014 ;349(2):268-78

저서

저서 내용이 없습니다.

보도자료

보도자료 내용이 없습니다.

포스팅

포스팅 내용이 없습니다.

영상자료

영상자료 내용이 없습니다.

발표자료

발표자료 내용이 없습니다.